Breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: Weight loss diet consultation (At the beginning of the study all the participants, according to their age, height, weight and calculating Energy
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: Female breast cancer survivors (or Cessation of menstruation for at least 6 months prior to chemotherapy) Age range (50-75) BMI = 25 - 40 Kg/m2 At least one month has passed since the last radiotherapy Complete treatment of stage 1 - 4 breast cancer survivors Type of breast cancer : ER/PR+ and HER2- Willingness to cooperate and sign a written informed consent
Exclusion criteria
Exclusion criteria: History of Diabetes, acute heart failure, cirrhosis hepatic, acute and chronic renal failure History of autoimmune and infectious disease weight loss diet during the 6 months prior to study Smoking Alcohol consumption Nutrition supplement consumption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adiponectin. Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor Necrosis Factor alpha (TNF-a). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.;High-sensitivity C-reactive protein (hs-CRP). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.;Apolipoprotein-A1 (Apo-A1). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.;Apolipoprotein-B100 (Apo-B100). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Raji Lahiji
Iran University of Medical Sciences
Outcome results
None listed